Matthew Dolan is the VP of DexCom, a major medical technology firm that specializes in Continuous Glucose Monitoring systems for ambulatory use of diabetic individuals.
His company is a leader in the industry and has taken its place at the forefront of medical technology firms thanks in no small part to Matthew and his work with the organization. He is a driven, talented, and compassionate individual with experience and knowledge that places him in a unique position to help others.
His knowledge comes from an educational background at Northwestern University, where he studied pre-med and economics. These are two very different studies, but he found their backgrounds to be uniquely complementary. Mr. Dolan is a man who recognizes the importance of diverse areas of knowledge. His experience in both business and medicine informs his current work and pursuits.
After graduating from Northwestern, Matthew Dolan took on a role with Roth Capital Partners. In 2006 he started working with the investment bank and his work focused on the evaluation of growing companies and potential investors. Matthew’s work as an analyst provided insights into major medical companies and trends within the marketplace. In this role, he developed an impressive set of skills and experiences that continue to serve as the foundation of his work in the field. In this role, he oversaw dozens of relationships with medical companies of all kinds. After working hard in this role for nearly 3 years he was promoted to Senior Research Analyst, cementing a role that would last nearly a decade.
But as all good things do, Matt’s time with Roth Capital ended. In 2013 he left for a business that he developed a good working relationship with – Volcano Corporation. They accepted him into their ranks, giving him the position of Director of Business Development. Here Matthew would become a leading expert, focusing on acquisitions, investments, partnerships, and more. He worked with Volcano for nearly 3 years, developing a love for the industry, and an eye that saw the future he could lead them towards. He left a lasting legacy at Volcano and the organization was acquired by Philips after he left in 2015.
Matthew Dolan’s current and most long-lasting position is with DexCom Inc., which he continues to work towards developing as a high-ranking official in the company. He began at DexCom as the Vice President of Corporate Development, which allowed him to develop a wealth of knowledge and understanding of the corporate culture and field. He has been a key player in the development of major partnerships, including major organizations in the healthcare industry like Eli Lily. He is very involved in the long-term success and growth of the company, and he has since presented a strategy and plan to the board of directors. This presentation included the central projects of the company as well as new market initiatives for the company to pursue, including non-intensive diabetes management, population health, hospital, and gestational diabetes.
Today, Matthew Dolan has been given two major titles with DexCom: Senior Vice President and General Manager of New Markets. He has displayed a keen interest in new markets and the potential for growth that they represent. He led the charge on the development of the New Markets division, and he has been responsible for the rapid growth and creation of nearly a hundred jobs.
